KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Shares Repurchased: 2024-2025

Historic Shares Repurchased for Aurinia Pharmaceuticals (AUPH) over the last 2 years, with Sep 2025 value amounting to $8.7 million.

  • Aurinia Pharmaceuticals' Shares Repurchased was N/A to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.0 million, marking a year-over-year change of. This contributed to the annual value of $40.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Shares Repurchased is $8.7 million, which was down 79.63% from $42.6 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' Shares Repurchased's 5-year high stood at $46.9 million during Q1 2025, with a 5-year trough of $6.1 million in Q2 2024.
  • Moreover, its 2-year median value for Shares Repurchased was $17.1 million (2024), whereas its average is $23.1 million.
  • Data for Aurinia Pharmaceuticals' Shares Repurchased shows a peak YoY spiked of 593.90% (in 2025) over the last 5 years.
  • Over the past 2 years, Aurinia Pharmaceuticals' Shares Repurchased (Quarterly) stood at $21.8 million in 2024, then surged by 593.90% to $8.7 million in 2025.
  • Its Shares Repurchased was $8.7 million in Q3 2025, compared to $42.6 million in Q2 2025 and $46.9 million in Q1 2025.